Medical information, scientific resources and product information for healthcare professionals. This section is being built; product information is available now.
For adverse drug reactions or medicine-safety information, please use the dedicated pharmacovigilance channel. Product quality concerns have their own route.
Report a suspected adverse drug reaction or medicine-safety concern. You can also report to the National Coordination Centre, Pharmacovigilance Programme of India.
Tell us the product, batch number and the concern. Product quality is a shared responsibility, and every report is reviewed.
Comments shared with us by prescribing clinicians about our field communication and product information. This section is intended for registered medical practitioners.
The information below relates to prescription-only medicines and is intended solely for registered healthcare professionals in India. It is not promotional material directed at the general public.
I appreciate HOLYMED PHARMA’s professional approach to healthcare communication. The Metawell portfolio, including CVROZ and BISOWIN, is presented with clear product information and a focus on cardiovascular care. The team maintains consistent and professional interaction with healthcare professionals.
My interaction with HOLYMED PHARMA has been professional and constructive. I appreciate the company’s efforts to communicate information about its cardiovascular portfolio, including CVROZ, BISOWIN and HOLYTICA 90 MG. Their systematic approach to professional communication is appreciated.
HOLYMED PHARMA has maintained a professional approach in presenting its product range. The product information regarding PROXYFLAM SP and ETRIFLEX TH4 has been communicated clearly, and I appreciate the team’s regular professional interaction and responsiveness.
I appreciate the professional communication and product-focused approach of the HOLYMED PHARMA team. The Painbuster portfolio, including CHYSON BR and DQUIK, has been presented in a clear and systematic manner. The team is approachable and responsive during professional interactions.
The Metawell portfolio has been presented by HOLYMED PHARMA with a clear focus on product information and professional communication. I appreciate the team’s efforts in discussing products such as DAPARMIS and HOLYGLIZ M XR in a structured manner.
My professional interaction with HOLYMED PHARMA has been positive. I appreciate the company’s approach to communicating its products and maintaining regular interaction with healthcare professionals. The Painbuster and nutritional-support portfolio has been presented in a professional and informative manner.
Comments are reproduced as provided by the named practitioners with their consent, and relate to HOLYMED PHARMA’s professional communication and product information rather than to clinical outcomes. They are not a recommendation to prescribe, do not constitute clinical advice, and must not be used as a substitute for the approved prescribing information. Prescribing decisions rest solely with the treating clinician. All products referred to are prescription-only medicines to be used strictly under medical supervision.
Composition, strengths and pack sizes for all 43 brands are on the products page.